Ile164 variant of β2-adrenoceptor does not influence outcome in heart failure but may interact with β blocker treatment

European Journal of Heart Failure

Volumn 10, Issue 1, 2008, Pages 55-59

  Littlejohn, Mathew D ^a   Palmer, Barry R ^a   Richards, A Mark ^a   Frampton, Chris M ^a   Pilbrow, Anna P ^a   Troughton, Richard W ^a   Cameron, Vicky A ^a   Kennedy, Martin A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

blockers; 2 adrenoceptor; Genetic polymorphism; Heart failure

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ISOLEUCINE; NEUROHORMONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG RECEPTOR BINDING; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART FAILURE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; ALLELE; ANALYSIS OF VARIANCE; DRUG EFFECT; GENETICS; KAPLAN MEIER METHOD; MORTALITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALLELES; ANALYSIS OF VARIANCE; FEMALE; GENOTYPE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ADRENERGIC, BETA-2; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 37549040271     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.10.011     Document Type: Article

References (13)

1. Bristow M.R., Ginsburg R., Umans V., et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 59 (1986) 297-309
2. Gilbert E.M., Olsen S.L., Renlund D.G., and Bristow M.R. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol 71 (1993) 23C-29C
3. Green S.A., Cole G., Jacinto M., Innis M., and Liggett S.B. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268 (1993) 23116-23121
4. Turki J., Lorenz J.N., Green S.A., Donnelly E.T., Jacinto M., and Liggett S.B. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A 93 (1996) 10483-10488
5. Liggett S.B., Wagoner L.E., Craft L.L., et al. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102 (1998) 1534-1539
6. Pilbrow A.P., Palmer B.R., Frampton C.M., et al. Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure. Hypertension 49 2 (2007) 322-327
7. Collins R.P., and Palmer B.R. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. Am Heart J 152 (2006) 312-320
8. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
9. Palmer B., Pilbrow A., Frampton C., et al. ACE gene polymorphism interacts with LVEF and BNP levels to predict mortality following myocardial infarction. J Am Coll Cardiol 41 (2003) 729-736
10. Littlejohn M.D., Taylor D.R., Miller A.L., and Kennedy M.A. Determination of beta2-adrenergic receptor (ADRB2) haplotypes by a multiplexed polymerase chain reaction assay. Hum Mutat 20 (2002) 479
11. Xiao R.P., Ji X., and Lakatta E.G. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47 2 (1995) 322-329
12. Zhu W.Z., Zheng M., Koch W.J., Lefkowitz R.J., Kobilka B.K., and Xiao R.P. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A 98 4 (2001) 1607-1612
13. Communal C., Singh K., Sawyer D.B., and Colucci W.S. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100 22 (1999) 2210-2212